The Novembers are thrilled to partner once again with the Cleveland Clinic through at $1 million endowed chair in the Lerner Research Institute: The Mort and Iris November Distinguished Chair in Innovative Breast Cancer Research. Immunologist Vincent Tuohy is the chair's beneficiary, a researcher who's work caught Mrs. November's eye last April.
Money from the endowment's investments won't directly be used to pay for clinical trials, but it will help Tuohy sustain his six-person laboratory, which also is working on preventive vaccines for ovarian and prostate cancers. Tuohy said he would like to hire more postdoctoral researchers to work on new projects.
"I feel the momentum is growing," he said of interest in the breast cancer vaccine. "I feel that the resistance in the research community . . . is weakening."